📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest. (2022)

First Author: Moss P

Attributed to: Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2022.05.067

PubMed Identifier: 35718592

Publication URI: http://europepmc.org/abstract/MED/35718592

Type: Journal Article/Review

Volume: 40

Parent Publication: Vaccine

Issue: 32

ISSN: 0264-410X